CST3 and acute kidney injury: We found that dodecafluorpentan ameliorated the pathogenesis of AKI triggered by IRI, as evidenced by reduced levels of BUN (Fig. 6f), Scr (Fig. 6g), and cystatin C (Fig. 6h), as well as the preservation of renal structure (Fig. 6k and l).